| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/20/1999 | CA2133649C Oral infection of insect larvae with pre-occluded baculovirus particles |
| 04/15/1999 | WO1999018226A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | WO1999018220A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | WO1999018216A2 Chimeric vaccine against tick-borne encephalitis virus |
| 04/15/1999 | WO1999018215A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 04/15/1999 | WO1999018214A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 04/15/1999 | WO1999018194A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 04/15/1999 | WO1999017802A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | WO1999002666A3 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 04/15/1999 | DE4447664C2 Recombinant papilloma virus-like particles contg. L1 or L2 proteins |
| 04/15/1999 | CA2306182A1 Gene deleted recombinant felv proviral dna for production of vaccines against felv |
| 04/15/1999 | CA2305382A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | CA2305182A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | CA2304350A1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0907746A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV |
| 04/14/1999 | CN1213699A Prodn. system of novel recombination adenovirus adjoint virus |
| 04/08/1999 | WO1999016891A1 Methods of replicating virus in monocyte-derived macrophage cultures |
| 04/08/1999 | WO1999016866A1 A method for generating nonpathogenic, infectious birnavirus from synthetic rna transcripts |
| 04/08/1999 | WO1999004026A3 Lentiviral vectors |
| 04/08/1999 | WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/08/1999 | CA2305622A1 Methods of replicating virus in monocyte-derived macrophage cultures |
| 04/08/1999 | CA2246626A1 Rabies recombinant adenovirus |
| 04/07/1999 | EP0906442A1 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins |
| 04/07/1999 | EP0906441A1 Antitumour cellular compositions expressing at least three transgenes |
| 04/07/1999 | EP0906019A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 04/07/1999 | EP0689447B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/07/1999 | CN1213317A Method and apparatus for inactivating contaminants in biological fluid |
| 04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
| 04/06/1999 | US5891723 Large granular lymphocyte leukemia associated virus |
| 04/06/1999 | US5891705 Monomeric or oligomeric ethylenimine |
| 04/06/1999 | US5891676 Recombinant molecule which contains baculovirus promoter spatially positioned with rotovirus protein vp2 gene; effective gene regulation; vaccine for animals and humans against diarrheal disease |
| 04/06/1999 | US5891648 Reaction-based selection for expression of and concentration of catalytic moieties |
| 04/06/1999 | US5891624 Methods of culturing and assaying a virus in a specimen |
| 04/06/1999 | US5891431 Biopesticides |
| 04/06/1999 | CA2064705C Methods for culturing hcv in eukaryotic cells |
| 04/06/1999 | CA2000159C Bacterial detection by phage transduction of detectable phenotype |
| 04/01/1999 | WO1999015686A1 Plasmids for construction of eukaryotic viral vectors |
| 04/01/1999 | WO1999015685A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 04/01/1999 | WO1999015684A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | WO1999015683A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 04/01/1999 | WO1999015672A1 Attenuated respiratory syncytial viruses |
| 04/01/1999 | WO1999015641A1 Non-primate lentiviral vectors and packaging systems |
| 04/01/1999 | WO1999015631A1 Recombinant rsv virus expression systems and vaccines |
| 04/01/1999 | WO1999015630A1 Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy |
| 04/01/1999 | WO1999015509A2 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems |
| 04/01/1999 | WO1998052964A9 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
| 04/01/1999 | WO1998051660A9 Methods and compositions for the selective modification of nucleic acids |
| 04/01/1999 | WO1998039464A8 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/01/1999 | DE19741739A1 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use |
| 04/01/1999 | CA2820212A1 Recombinant rsv virus expression systems and vaccines |
| 04/01/1999 | CA2304983A1 Non-primate lentiviral vectors and packaging systems |
| 04/01/1999 | CA2304932A1 Recombinant rsv virus expression systems and vaccines |
| 04/01/1999 | CA2304259A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 04/01/1999 | CA2304173A1 Plasmids for construction of eukaryotic viral vectors |
| 04/01/1999 | CA2304168A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 04/01/1999 | CA2303663A1 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | CA2302867A1 Attenuated respiratory syncytial viruses |
| 04/01/1999 | CA2301641A1 Supramolecular pairing system, its preparation and use |
| 03/31/1999 | EP0905246A1 Cloning of chicken anaemia DNA |
| 03/31/1999 | EP0905140A1 Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
| 03/31/1999 | EP0904395A1 Herpes simplex virus strains |
| 03/31/1999 | EP0904394A1 Chicken embryo lethal orphan (celo) virus |
| 03/31/1999 | EP0904392A1 Retroviral vectors |
| 03/31/1999 | EP0904379A2 Simian-human hav having a chimeric 2c protein |
| 03/31/1999 | EP0904351A1 Animal cells and processes for the replication of influenza viruses |
| 03/31/1999 | EP0903981A1 Design of novel highly efficient hiv based packaging systems for gene therapy |
| 03/30/1999 | US5889176 Nucleic acid molecules encoding non-infectious, non-replicating, HIV retrovirus-like particles containing heterologous antigenic anchor sequences |
| 03/30/1999 | US5889174 Nucleotide sequences encoding pesticidal proteins |
| 03/30/1999 | US5889158 Methods and kits for the detection of human immunodeficiency virus type 2 employing HIV-2 specific antibodies and antigens |
| 03/30/1999 | US5889156 TNF deletion muteins |
| 03/30/1999 | US5888801 Bacillus thuringiensis |
| 03/30/1999 | US5888767 Method of using a conditionally replicating viral vector to express a gene |
| 03/30/1999 | US5888513 Porcine reproductive and respiratory syndrome virus proteins, and amino acid sequences encoding them; produced in a baculovirus expression system using insect cell cultures as host |
| 03/30/1999 | US5888502 Recombinant retroviruses |
| 03/30/1999 | CA1340473C Method for isolating herpes virus thymidine kinase-encoding dna |
| 03/25/1999 | WO1999014354A1 Methods and vector constructs useful for production of recombinant aav |
| 03/25/1999 | WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 03/25/1999 | WO1999013818A2 Membrane virus host range mutations and their uses as vaccine substrates |
| 03/25/1999 | CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 03/24/1999 | EP0739413B1 Method of selecting specific bacteriophages |
| 03/23/1999 | US5885963 Administering to said pests, or the environment of said pests, a pesticidally effective amount of a bacillus thuringiensis delta-endotoxin from the bacillus thuringiensis isolate ps123d1 |
| 03/23/1999 | US5885822 A human skin graft is infected with molluscum contagiosum virus attached to or beneath a skin section of immunocompromised host, where the infection results in the productive molluscum contagiosum virus replication |
| 03/23/1999 | US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting |
| 03/23/1999 | US5885793 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/23/1999 | US5885603 Insecticidal matrix and process for preparation thereof |
| 03/23/1999 | US5885585 Virus derived from 65th passage of cpv-39; vaccines against canine parvovirus or feline panleukopenia virus |
| 03/23/1999 | US5885569 Biological insect control agent |
| 03/18/1999 | WO1999013073A2 Viral vector system capable of expressing an apoptosis-associated gene |
| 03/18/1999 | WO1999013064A2 Viral infection of cells using viral vectors |
| 03/18/1999 | WO1999013056A1 IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs) |
| 03/18/1999 | WO1999012948A2 Protein-coated polyribonucleic acids, method for the production thereof, and use of the same |
| 03/17/1999 | EP0901523A1 Immortalized avian cell lines |
| 03/17/1999 | EP0614465B1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
| 03/17/1999 | CN1211277A Systems and methods for removing viral agents from blood |
| 03/16/1999 | US5883081 Isolation of novel HIV-2 proviruses |
| 03/16/1999 | US5882913 Protecting plants |
| 03/16/1999 | US5882912 Retrovirus isolated from humans |